Tagged with R

Innovation Meghann Chilcott, Senior Vice President of OrderInsite, discusses the changing role of pharmacists and technicians.   Patients are consumers, and they expect more from pharmacies than a collection of pill bottles. Local pharmacists have seen their roles continually change over recent years due to enhanced technology that allows them better…

Europe At last week’s European Health Forum Gastein (EHFG), the theme surrounded the United Nations Sustainable Development Goals (SDGs) for 2030. Out of the 17 SDGs, 12 are in some way connected to health and nutrition. In attendance were key stakeholders in European health including Martin Seychell, deputy director of health…

China Professor Richard Barker, founder of New Medicine Partners reflects on China’s very different approach to the biopharma industry.   Napoleon once said: “China is a sleeping giant. Let her sleep, for when she wakes she will shake the world.” Well, in biotech, she is now wide awake I’ve recently returned from…

France Key statistics on the workforce, revenue, investment levels, R&D spending and consumption in the French pharmaceutical industry today. Mapping the 32 biopharma production sites in France, including the location, company and products produced. France ranks fourth in the EU for pharma production with EUR 20.981 billion in value, behind Switzerland,…

Spain Enrique Ruiz Escudero, Minister of Health of the Community of Madrid, discusses his strategy to maintain Madrid’s spot as having Spain’s leading healthcare system, the creation of the bio-region –‘Biomad’, and the city’s adoption of innovative telemedicine practices. You took the reins of the Ministry of Health of the Community…

Regulation Dominique Martin, CEO of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé) provides a fascinating insight into the French process of authorizing drugs and medical products, his commitment to increased transparency and increased efficiency, and the opportunity for France to take the lead in European…

Algeria The Top 20 Pharma Companies in Algeria based on sales in 2017. Sanofi is way out in front with USD 458.6 million in sales, followed by local champion El Kendi with USD 254.1 million and Danish diabetes specialist Novo Nordisk with USD 239.1 million.

Hong Kong Tim Collins of DCH Auriga outlines the Asia-Pacific healthcare distribution landscape, DCH’s expansion plans and what Hong Kong offers as a regional headquarters.   After 14 years with LF Asia, you joined DCH and were actively involved in the recent acquisition. What are the key learnings that you are bringing…

Turkey Ece Kaşıkçı, General Manager, Bristol-Myers Squibb (BMS) Turkey, outlines how BMS’ groundbreaking immuno-oncology therapy has proudly become the first product of its kind to be registered and reimbursed in the country. She also highlights the company’s collaborative approach to reach this remarkable milestone. Ece also discusses her vision for BMS…

Spain Ignacio Vega and Carlos Ibares Sanz of Spanish medtech Cardiva, explain the group’s origins as a distributor, the growing importance of manufacturing, and the company’s international ambitions.   How has Cardiva evolved since its formation in Bilbao in 1989? Ignacio Vega (IV): Cardiva began life as a distributor, primarily for…

Algeria With non WTO members such as Algeria flouting intellectual property (IP) it raises the issue of how best to protect and price medicines in the future. In a fascinating interview we spoke to Rachid Kerrar from the Algerian firm Beker about their development of a cheaper, generic version of Gilead’s…

regulation Chinese ecommerce behemoths Alibaba and JD.com are being used to buy and sell tens of thousands of prescription medicines, skirting regulations in what is a legal grey area. According to a recent Financial Times report, dozens of listings from third party vendors – mainly pharmacies – for drugs such as…